You have actually raised a very interesting question, although I doubt you realised it.
The reason almost all pharmaceutical companies are trying to develop targeted drugs and immunotherapies is because it is near impossible to make a better version of the current generic chemo drugs. Take doxorubicin (a member of the anthracycline class) as an example, pharma companies have made over 2000 different anthracyclines and none have proven sufficient superior to doxorubicin to make the switch worthwhile. Unless you can make a chemo drug that is significantly better than the current chemo drugs you don’t have commercially viable drug program.
This is where bisantrene is different. It is a drug that is significantly better than the current chemo drugs, but probably most importantly we are not trying to replace the current chemo drugs, but make them safer and more effective by adding bisantrene on top. Based on our research (which we have shared with the market) this is a very attractive market with significant value.
- Forums
- ASX - By Stock
- RAC
- Industry news
Industry news, page-1988
-
-
- There are more pages in this discussion • 404 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.78 |
Change
-0.005(0.28%) |
Mkt cap ! $305.0M |
Open | High | Low | Value | Volume |
$1.80 | $1.84 | $1.78 | $133.8K | 73.76K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 15072 | $1.78 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.87 | 1793 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2482 | 1.805 |
1 | 694 | 1.795 |
2 | 557 | 1.790 |
1 | 560 | 1.785 |
3 | 15400 | 1.780 |
Price($) | Vol. | No. |
---|---|---|
1.780 | 4294 | 1 |
1.870 | 1793 | 1 |
1.880 | 2351 | 1 |
1.890 | 1000 | 1 |
1.895 | 7800 | 1 |
Last trade - 16.10pm 01/10/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
Previous Video
Next Video
SPONSORED BY The Market Online